Miromatrix
S01E82 : SYNTHETIC ORGANO 3/3 : MIROMATRIX
File open 11 August 2026: Miromatrix / Synthetic Organo.
Health
Health
Miromatrix
NOTES: Miromatrix: Organ Arbitrage: The 60% Scaffold Scam
Marcus on Miromatrix: the spin vs the invoice.
Miromatrix
AUDIT: Miromatrix: Organ Arbitrage: The Biological Wall at Miromatrix
Forensic audit of Miromatrix under Synthetic Organo.
United Therapeutics
NOTES: United Therapeutics: Flesh, Fiction, and the 47-Day Vending Machine
Marcus on United Therapeutics: the spin vs the invoice.
United Therapeutics
AUDIT: United Therapeutics: The Anatomy of a Biological Default
Forensic audit of United Therapeutics under Synthetic Organo.
United Therapeutics
S01E77 : SYNTHETIC ORGANO 2/3 : UNITED THERAPEUTICS
File open 09 August 2026: United Therapeutics / Synthetic Organo.
Tech-Fail
NOTES: Synthetic Organs: A Biological Payday Loan
Synthetic organs aren't a cure; they're a biological payday loan. From $2 million ears to pig lungs, welcome to the two-tier abattoir of organ arbitrage.
Cassandra Protocol
S01E74 : SYNTHETIC ORGANO 1/3 : TELO (3D BIO)
August 1, 2026. The Cassandra Protocol opens the SYNTHETIC ORGANO archive — organ bioprinting, xenotransplantation, and a tiered market for flesh.
Xenotransplantation
AUDIT: Synthetic Organs: The Vascularization Wall
Synthetic biology faces a Brutalist restructuring. Discover how the Vascularization Wall and the BIOSECURE Act are driving a new era of Organ Arbitrage.
Cassandra Protocol
S01E68 : MICROBIOME FACTORY 3/3 : FINCH THERAPEUTICS
The server room shouldn't be here. Hidden deep beneath the cracked red rock of the Sedona desert. The Cassandra Protocol initiated. The organic dream failed.
Billion-Dollar Toilet
NOTES: System: Hundred-Million-Dollar Mud
Finch Therapeutics tried to build a billion-dollar moat out of human waste. Now it's a $17M zombie giant. A look at the hubris of the billion-dollar toilet.
Finch Therapeutics
AUDIT: System: Hundred-Million-Dollar Mud
How regulatory frameworks and FDA CMC guidelines dismantled Finch Therapeutics' $1 billion microbiome moat. A forensic audit of a biological market collapse.